Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/152378
Title: High Prevalence of Strongyloidiasis in Spain: A Hospital-Based Study
Author: Requena-Méndez, Ana
Salas-Coronas, Joaquín
Salvador, Fernando
Gómez Junyent, Joan
Villar Garcia, Judith
Santín Cerezales, Miguel
Muñoz, Carmen
González Cordón, Ana
Cabezas Fernández, Maria Teresa
Sulleiro, Elena
Arenas-Miras, Maria del Mar
Somoza, Dolors
Vazquez Villegas, Jose
Treviño, Begoña
Rodríguez de las Parras, Esperanza
Valls, M. Eugenia
Llaberia Marcual, Jaume
Subirà, Carme
Muñoz, José
Keywords: Nematodes
Malalties parasitàries
Nematodes
Parasitic diseases
Issue Date: 11-Feb-2020
Publisher: MDPI
Abstract: Introduction: Strongyloidiasis is a prevailing helminth infection ubiquitous in tropical and subtropical areas, however, seroprevalence data are scarce in migrant populations, particularly for those coming for Asia. Methods: This study aims at evaluating the prevalence of S. stercoralis at the hospital level in migrant populations or long term travellers being attended in out-patient and in-patient units as part of a systematic screening implemented in six Spanish hospitals. A cross-sectional study was conducted and systematic screening for S. stercoralis infection using serological tests was offered to all eligible participants. Results: The overall seroprevalence of S. stercoralis was 9.04% (95%CI 7.76–10.31). The seroprevalence of people with a risk of infection acquired in Africa and Latin America was 9.35% (95%CI 7.01–11.69), 9.22% (7.5–10.93), respectively. The number of individuals coming from Asian countries was significantly smaller and the overall prevalence in these countries was 2.9% (95%CI −0.3–6.2). The seroprevalence in units attending potentially immunosuppressed patients was significantly lower (5.64%) compared with other units of the hospital (10.20%) or Tropical diseases units (13.33%) (p < 0.001). Conclusions: We report a hospital-based strongyloidiasis seroprevalence of almost 10% in a mobile population coming from endemic areas suggesting the need of implementing strongyloidiasis screening in hospitalized patients coming from endemic areas, particularly if they are at risk of immunosuppression.
Note: Reproducció del document publicat a: http://dx.doi.org/10.3390/pathogens9020107
It is part of: Pathogens, 2020, vol. 9, num. 2
URI: http://hdl.handle.net/2445/152378
Related resource: http://dx.doi.org/10.3390/pathogens9020107
ISSN: 2076-0817
Appears in Collections:Articles publicats en revistes (ISGlobal)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (Medicina)
Articles publicats en revistes (Ciències Clíniques)

Files in This Item:
File Description SizeFormat 
Requena-MendezA_Pathogens_2020.pdf729.85 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons